As Federal Reserve Flinches, This Official Sees No Harm in Waiting and Watching

As Federal Reserve Flinches, This Official Sees No Harm in Waiting and Watching

Federal Reserve officials last week scrapped a pledge to be 'patient'' when deciding whether to cut U.S. interest rates to ward off an economic downturn. The move was seen as inching the Fed closer to a possible reduction in July. But Robert Kaplan, president of the central bank's Dallas branch, argues in a new essay that 'additional time' is needed to evaluate whether to make any changes in monetary policy.

AbbVie Joins Giant Acquisition Trend in Big Pharma With Allergan Deal

AbbVie Joins Giant Acquisition Trend in Big Pharma With Allergan Deal

The proposed, $63 billion transaction is the latest deal in an industry where it can be cheaper to buy the science of another company than develop products.

Charts of the Day: The States of U.S. Gambling

Charts of the Day: The States of U.S. Gambling

A bit of context to simmer on following the big deal between Caesars and Eldorado.

As Economy Creeps Into Old Age, Amazon's Bank Bets on Buyers With Bad Credit

As Economy Creeps Into Old Age, Amazon's Bank Bets on Buyers With Bad Credit

Synchrony, the bank spun off from General Electric in 2014, has posted impressive asset growth and profitability in recent years. But some investors are leery of the stock because of the potential for steep losses if the U.S. economy takes a turn for the worse.

U.S. Banks Pass Fed's 'Stress Test' With Room for Dividends, Buybacks

U.S. Banks Pass Fed's 'Stress Test' With Room for Dividends, Buybacks

The Federal Reserve's 'stress tests' of big banks requires them to maintain sufficient capital, even after a nightmare economic scenario in which stock prices fall by 65% and unemployment surges to 10%.

Prohibition and the Paradoxical Proclivity of Cannabis Consumption

Prohibition and the Paradoxical Proclivity of Cannabis Consumption

Is prohibition the real factor propping up projections for demand and pricing in the cannabis market?

Hero or Scourge? Federal Reserve's Lone Wolf Explains Dissent on Interest Rates

Hero or Scourge? Federal Reserve's Lone Wolf Explains Dissent on Interest Rates

James Bullard, president of the Federal Reserve Bank of St. Louis, was the only member of the Federal Reserve's monetary-policy committee to vote this week for a cut in the official U.S. interest rate. The panel majority, led by Chair Jerome Powell, voted to keep the rate at 2.25% to 2.5% but warned of risks to the U.S. economy.

Can Oracle Retake Lost Market Share -- Or Is It In the Clouds?

Can Oracle Retake Lost Market Share -- Or Is It In the Clouds?

Oracle tells investors it can regain the crown it once held among enterprises and end-users, but some aren't so sure.

Wall Street Is Still Waiting on the Oracle Debate to Settle

Wall Street Is Still Waiting on the Oracle Debate to Settle

Is the bad news for Oracle all over?

Tencent-Backed WeDoctor Scraps International Listing for Shanghai

Tencent-Backed WeDoctor Scraps International Listing for Shanghai

The healthcare app creator reportedly shelves a Hong Kong listing in favor of "China's Nasdaq" due to data privacy and transparency concerns.